University of Connecticut:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:University of Connecticut - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C9405
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:33
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
University of Connecticut (UCONN) is an educational service provider that offers graduation programs and other courses. The university offers undergraduate degree courses, graduate degree courses, professional degree programs, and research programs. It offers educational and training programs in business, dental medicine, health and natural resources, agricultural, engineering, fine arts, liberal arts and sciences, law, nursing, pharmacy and social work areas, among others. UCONN also conducts research on advanced materials characterization, biomedical devices, advanced materials and manufacturing, cyber security and others. The university operates through its labs, lecture halls and community facilities in Connecticut. UCONN is headquartered in Storrs, Connecticut, the US.

University of Connecticut – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
University of Connecticut, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
University of Connecticut, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
University of Connecticut, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
University of Connecticut, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
University of Connecticut, Medical Devices Deals, 2012 to YTD 2018 9
University of Connecticut, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
University of Connecticut, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
LambdaVision Raises US$0.11 Million In Venture Financing 11
Partnerships 12
Biohaven Pharma and University of Connecticut Enter into Research Agreement 12
CaroGen Enters into Agreement with University of Connecticut 13
Immunovaccine Extends Partnership with UConn Health 14
Jackson Labs and University of Connecticut Form Joint Venture 15
Licensing Agreements 16
Biohaven Pharma Enters into Licensing Agreement with University of Connecticut 16
HedgePath Pharma Enters into Option Agreement with University of Connecticut 17
University of Connecticut – Key Competitors 18
University of Connecticut – Key Employees 19
University of Connecticut – Locations And Subsidiaries 20
Head Office 20
Other Locations & Subsidiaries 20
Recent Developments 21
Government and Public Interest 21
Aug 10, 2018: Icahn Institute partners in $6.5 million NIH award to advance precision medicine and bioengineering capabilities 21
May 17, 2018: UConn Researchers Lead National Effort to Improve Drug Manufacturing 22
Apr 02, 2018: New Compound Helps Activate Cancer-Fighting T Cells 24
Mar 19, 2018: New Study Identifies Effective Treatments for Persistent Asthma 26
Oct 10, 2017: National MS Society Commits Nearly $14 Million to New Research to Stop Multiple Sclerosis, Restore Function and End MS Forever 28
Apr 24, 2017: Stem cells help researchers identify neuronal defects causing Angelman syndrome 29
Product News 31
Jan 15, 2018: Biodegradable Sensor Monitors Pressure in the Body then Disappears 31
Appendix 33
Methodology 33
About GlobalData 33
Contact Us 33
Disclaimer 33

List of Tables
University of Connecticut, Pharmaceuticals & Healthcare, Key Facts 2
University of Connecticut, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
University of Connecticut, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
University of Connecticut, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
University of Connecticut, Deals By Therapy Area, 2012 to YTD 2018 8
University of Connecticut, Medical Devices Deals, 2012 to YTD 2018 9
University of Connecticut, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
LambdaVision Raises US$0.11 Million In Venture Financing 11
Biohaven Pharma and University of Connecticut Enter into Research Agreement 12
CaroGen Enters into Agreement with University of Connecticut 13
Immunovaccine Extends Partnership with UConn Health 14
Jackson Labs and University of Connecticut Form Joint Venture 15
Biohaven Pharma Enters into Licensing Agreement with University of Connecticut 16
HedgePath Pharma Enters into Option Agreement with University of Connecticut 17
University of Connecticut, Key Competitors 18
University of Connecticut, Key Employees 19
University of Connecticut, Subsidiaries 20

List of Figures
University of Connecticut, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
University of Connecticut, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
University of Connecticut, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
University of Connecticut, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
University of Connecticut, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
University of Connecticut, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
University of Connecticut, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
University of Connecticut, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
University of Connecticut, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[University of Connecticut:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Institute for Research in Immunology and Cancer-製薬・医療分野:企業M&A・提携分析
    Summary Institute for Research in Immunology and Cancer (IRICoR), a subsidiary of University of Montreal is a non-profit research institute that offers drug discovery and commercialization services. The institute offers discovery, development and commercialization of novel drugs in oncology. It has …
  • Boralex Inc:発電所・企業SWOT分析
    Boralex Inc - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees (execut …
  • Navistar International Corporation:企業の戦略・SWOT・財務情報
    Navistar International Corporation - Strategy, SWOT and Corporate Finance Report Summary Navistar International Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • Arise AB (ARISE):電力:M&Aディール及び事業提携情報
    Summary Arise AB (Arise) is an integrated onshore wind company. It involves in project development and sale of electricity generation through its onshore wind turbines. The company manages exploration, construction, sale, long-term management and financing of its own and third party wind farms. Aris …
  • Sonoco Products Co (SON):企業の財務・戦略的SWOT分析
    Sonoco Products Co (SON) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • AES Gener SA (AESGENER):企業の財務・戦略的SWOT分析
    AES Gener SA (AESGENER) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Magellan Midstream Partners LP (MMP):企業の財務・戦略的SWOT分析
    Magellan Midstream Partners LP (MMP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Queen Mary University of London-製薬・医療分野:企業M&A・提携分析
    Summary Queen Mary University of London (Queen Mary), formerly Queen Mary and Westfield College, a subsidiary of University of London, is a research university that offers undergraduate and postgraduate education; and research programs. The university provides graduation and education services in ar …
  • Adenovir Pharma AB:製薬・医療:M&Aディール及び事業提携情報
    Summary Adenovir Pharma AB (Adenovir Pharma) focuses on the development of antiviral pharmaceutical solutions for the treatment of infectious eye diseases such as adenoviral conjunctivitis and epidemic keratoconjunctivitis (EKC). The company’s APD-209 is topical pharmaceutical product that prevents …
  • Swan Life Ltd.:企業の戦略・SWOT・財務情報
    Swan Life Ltd. - Strategy, SWOT and Corporate Finance Report Summary Swan Life Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • L’Oreal USA Inc:企業の戦略的SWOT分析
    L'Oreal USA Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servic …
  • Aethlon Medical Inc (AEMD):医療機器:M&Aディール及び事業提携情報
    Summary Aethlon Medical Inc (Aethlon Medical) is a developer of therapeutic technologies that address unmet needs in biodefense and global health. It develops immunotherapeutic technologies for the treatment of cancer and infectious diseases. The company’s lead product, Hemopurifier, strengthens nat …
  • Global Voice Group SA:企業の戦略的SWOT分析
    Global Voice Group SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Rafako SA (RFK):企業の財務・戦略的SWOT分析
    Rafako SA (RFK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Ubiquiti Networks Inc:企業の戦略・SWOT・財務分析
    Ubiquiti Networks Inc - Strategy, SWOT and Corporate Finance Report Summary Ubiquiti Networks Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • China CITIC Bank Corporation Limited:企業の戦略・SWOT・財務情報
    China CITIC Bank Corporation Limited - Strategy, SWOT and Corporate Finance Report Summary China CITIC Bank Corporation Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysi …
  • Soventix GmbH:電力:M&Aディール及び事業提携情報
    Summary Soventix GmbH (Soventix) is a renewable energy company that develops and constructs solar plants and hybrid plants. The company’s services include planning and development, financing and management, and service and operations. Its projects include Essa Public School, 40 Holtby, Seaboard, Res …
  • Clayton Homes Inc:企業の戦略・SWOT・財務情報
    Clayton Homes Inc - Strategy, SWOT and Corporate Finance Report Summary Clayton Homes Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Swallowfield PLC:企業の戦略・SWOT・財務情報
    Swallowfield PLC - Strategy, SWOT and Corporate Finance Report Summary Swallowfield PLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Petrolympic Ltd (PCQ):企業の財務・戦略的SWOT分析
    Summary Petrolympic Ltd (Petrolympic) is an oil and gas exploration and development company that acquires, explores and develops light crude oil and natural gas in North America. The company holds interests in conventional natural gas and light oil projects in Gaspe Peninsula of Quebec. It holds int …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆